Tag Archives: gynecological bed
Electronic medical records is an important measure to guarantee medical safety
In the establishment of electronic medical records as the core of hospital information systems, electronic medical records is an important measure to guarantee medical safety. Given the above, to accelerate the construction of hospital information, and lay a firm foundation background for electronic medical records and health records of the establishment and use of the network provide a strong platform.
Health records is equivalent to the database, leading through the Health Department, and under the hospital to coordinate to do, this is a public matter, not every unit of their own thing.
Electronic medical records, that electronic medical records, medical treatment is a record object and related health care activities recorded information repository, the repository of information to form a computer can handle, and safe storage and transport, the hospital authority Users can access it. Management of health records is the residents health (disease prevention, health protection, health promotion, etc.) the process of specification, the scientific record. Personal health of residents as the core, throughout the life course, covering a variety of health-related factors, to achieve multi-channel dynamic collection of information, to meet their own needs and health of residents in the management of information resources (documentation).
Electronic health records, also known as electronic health records, electronic health records that is the object on the health status of healthcare information repository. Ministry of Health is developing "second five" health development plan, including health information technology system is the "second five" important content and objectives. Implementation of electronic medical records, electronic medical records to establish and improve the core of hospital information systems is to achieve the important goal of modern hospital management measures, to promote the equalization of health services, health care management to promote scientific, standardized, specialized, fine, information technology development, improving health care services, protection of medical quality and medical safety, improve the hospital management has important and far-reaching impact.
In the establishment of electronic medical records as the core of hospital information systems, electronic medical records is an important measure to guarantee medical safety. Given the above, to accelerate the construction of hospital information, and lay a firm foundation background for electronic medical records and health records of the establishment and use of the network provide a strong platform. Health records is equivalent to the database, leading through the Health Department, and under the hospital to coordinate to do, this is a public matter, not every unit of their own thing.
Medical information: electronic medical records first force
Through telemedicine, doctors successfully Xinjiang Shanghai implemented a surgical patient; PLA 309 hospital doctors, by logging iPad mobile workstation, Taking command of a sudden comatose patient with rescue; iPad Drchrono service provider of electronic medical records to obtain Since DST founder Yuri Milner, including Russia (Yuri Milner), including 65 million investment; One Medical Clinic with the U.S. chain of information technology to bring cost advantages and economies of scale, smooth five rounds of financing.
These seemingly unrelated to the appearance, but point to the same trend: the most difficult nut to health care information technology field, beginning to achieve loose situation. From a single class of medical IT service providers access to venture capital favored to grab the software Gangster cloud services, hospital care market intelligence, moving from the top three hospitals have upgraded working system, to the local government to promote the social integration of the various measures of medical information systems medical information of the parties involved become clear, the production chain are increasingly forming the upper and lower ring. As the market supply and demand in the gradual and effective docking, the hospital\\ s profit model is expected to improve, and in the local government\\ s boost, the software service providers will grow faster and open space.
Force first electronic medical records
The first step in medical information, the promotion of electronic medical records through electronic health records, not only the patient\\ s condition and the treatment itself effectively track record preservation, but also significantly reduce the workload of doctors and hospitals to facilitate the timely diagnosis. Value of information surrounding the development of electronic medical records, many stakeholders, including patients, clinicians, hospital administrators, community health, medical insurance, public health, health administrators, research institutions, are expected to benefit, and telemedicine, separated diagnostics and other areas of large-scale space applications or can be synchronized to achieve a breakthrough. In addition, the wider social benefits of electronic medical records is based on the format of a unified electronic medical record, the government can use information and business systems platform interoperability, data exchange and business collaboration, and dynamic management of the health of residents, \"Poison milk \"and other similar public health emergencies will be possible early in the outbreak was discovered through an early warning system.
In foreign markets, many independent start-up company is positioned as electronic medical records service provider. Because the entry point at the front of the medical information industry chain, earnings outlook is relatively clear, its capital is also an olive branch after another. Headquartered in Silicon Valley DrChrono, with iPad platform provides electronic medical services, free version of the application can achieve a variety of functions: allows users to enter electronic medical records, arranging patient appointments, oral disease converted to text notes and photographs and video, writing and sent to the diagnosis pharmacies, etc., in order to reduce the workload of doctors; and value-added version of the charges which, for the hospital to provide greater storage capacity and medical billing and other functions.
DrChrono founded in February 2011 when the receive $ 675,000 in seed money, and later received the well-known incubator Y Combinator funding agencies. Founded in 2007, another of Practice Fusion, business is also a cloud to doctors electronic medical records, including records visits information, see the medical records, appointment registration, electronic prescriptions, laboratory orders and collect open test results, see the online health patients information. The early days of the Practice Fusion was primarily in charge mode, the brink of collapse because of profit difficulties. But the Obama administration bill requires the introduction of electronic health care system to achieve transformation, the implementation of electronic medical records and medical subsidies, the company came to life, and to establish free strategy to expand the size of the user, and thus attract investors, its current user more than 100,000 more medical records database as much as ten million copies and has been successful in several rounds of a total of up to $ 36 million financing.
Rapid growth of software service providers will be
Government boost, hospitals enthusiastic early adopters, a huge growth potential has also been given information service is worth looking forward to the new space, according to IDC, by 2010, China\\ s investment in health care IT market reached 120 billion. The next five years, China\\ s health information services market will be an annual growth rate of 15-30%. CCW Research predicts that in 2011 China put into health care information technology industry, the relative total growth of 25.5% in 2010. The software services faster than hardware development, according to the GMP consulting research, the investment structure, future medical information market will further decline in the proportion of investment in hardware, software and services, while the proportion of investment will be increased year by year.
High growth is expected to attract massive capital into the industry, international companies, Intel is the number of separate parallel digital medical enterprise, mobile marketing industry, others such as IBM, Oracle (Oracle), Cisco (Cisco), are also set up a professional the medical industry sectors. Domestic manufacturers, the focus on the medical information of the GEM software companies, such as Wei Ning, shares of Silver River, has been confirmed with high growth performance of the importance of this market and prospects. Main business covers the intelligent transportation, and medical wisdom of the Silver River shares, substantial growth performance during the first half of 2011, which the wisdom of medical service revenue 72,362,900 yuan, an increase of 208.47%.
Recently, from the whole health care system integration provider cloud, down to the sub-sub-industry software provider, a new round of merger integration is surging. August 2011, Kingdee Kingdee health through the acquisition of subsidiaries Shanghai, Guangzhou, Hui Tong Computer Co., Ltd. 75% stake in the transaction consideration of approximately $ 120 million. Subsequently, Kingdee 3,000 million in cash and 26 million yuan of non-cash assets of wisdom through the capital increase, which ultimately holds 81.48% stake. Kingdee, the end of 2009, UF UF medical software through its subsidiaries an easy 18 million yuan acquisition of Guangzhou Medical Software Limited. Neusoft Group is funded at 114.1 million yuan in early 2011 acquisition of the medical industry ERP vendors look Haikang letter 73.14% stake.
Prepare business integration software vendors frequently, equipment manufacturers are also actively restructuring desire Stock Watch. As a leading global communications solutions provider Huawei, is a typical representative of cloud computing is now advertising its major sites often appeared in the medical industry, vertical, and its introduction to \"cloud the pipe end\" architecture-based package of medical information solutions, and has specific surgeon Zhabei District, Shanghai City, North Hospital, \"Health cloud\" project. With the technological edge of information technology infrastructure and network familiarity, Huawei\\ s strategy from hard to soft transition will undoubtedly inject new vitality into the market and boosting the industry a new model.
Government assistance comprehensive medical information service platform
Although China has yet to have similar specific electronic medical record providers appear, but with the advantage of quick and easy, the application of information technology in China has been the growing popularity of the top three hospitals. From the People\\ s Liberation Army 309 Hospital of a case shows that when the patient\\ s condition suddenly turns dangerous, you can not back to the doctor the first time in the mobile medical workstation login through the iPad, access to workstations in the radiology records of patients, ultrasound, pathology and other imaging, ECG, monitoring, anesthesia, chemotherapy, radiotherapy, clinical diagnosis and treatment of electronic medical records and other information, real-time basis to understand the patient\\ s condition and the latest test results, issued instructions on the breathing machine, 30 seconds after the nurse had to push the ventilator to the bedside. A related statistics show that 926 hospitals surveyed, 70% have established a nurses station and other information systems in the laboratory, radiology, EKG and other key sections of the information system construction, and has been prepared to establish the proportion of respectively 66%, 60%, 48%.
The application of intelligent systems to simplify the work condition information transmission, integration and other aspects, the faster the patients get good relief Needless to say, but also enhance the efficiency of medical diagnosis and hospital management, granularity, and thus further enhance the hospital\\ s profitability. This is reflected in the chain of clinics on the more obvious, in view of information systems and operational ease of a high degree of replication, making the chain mode, the ability of scale and cost savings multiplied.
Generally speaking, conventional support each doctor clinic support staff of about 4-5, and by means of electronic medical records and other information, the United States One Medical Group\\ s clinics only 1.5 or less. Management to reduce operating costs while the clinic, doctors have more time to answer patient\\ s questions, the experience of both doctors and patients have been enhanced. In the profit model, One Medical support of the U.S. most insurance programs, but will charge an annual fee of $ 149-199. The company currently operates in San Francisco and New York, nine clinics, after five totaling $ 46.5 million financing, will be extended to 2011 years of its Silicon Valley and Washington, DC, opened five new clinics.
In China, most of the public hospital system is subject to the plight of the more difficult chain of copy medical information on the profitability of significant improvement is not obvious, and integrated medical information system with the ability of all levels of government, as the establishment of standards important promoter. Some of the first local government has begun to establish regional information service platform, to explore a sustainable mode of information, such as the Zhongshan municipal government on the design and planning of the trilogy, pay by the Government for the construction of regional health information service platform, and through secondary data development to attract pharmaceutical companies, health management companies; also the terminal based on personal family business, the establishment of dynamic information health records, practice management fees. It is said that this program has attracted both Huawei and other UF class enterprise software and also provoke the Legend of the Star, Oak Delin, Kun Jiuding, Xun Xiang investment venture bodies.
Although planning is still in the exploratory stage, the link is clear from the design to the actual implementation is still lagging behind, but the hospital beyond the single, integrated community-based management model may be a future trend. The next long period of time, local governments have put up the Ministry of Health is to promote health information technology will be the main force. The inter-regional cooperation to share medical information for health care resource constraints and uneven regional development in China, more efficient means to save medical resources, medical information management vision for the fine may eventually become a reality.
Medical device suppliers how to deal with the weight of FDA regulated
U.S. FDA issued to medical device and equipment suppliers are increasing year by year the warning letter, the health care market in the taut nerves at the same time, how to improve the efficiency of the market control it?
In the past five years, the world\\ s many contaminated products led to patient injury and death and end-users. In 2007, the toothpaste containing diethylene glycol and millions of lead-containing toys were recalled. In 2008, the U.S. FDA recall of contaminated heparin (a widely used in kidney dialysis patients after surgery and blood thinners to prevent blood clots), and milk containing melamine has led to thousands of serious incidents and more than infant mortality. In 2009, due to flavor foods containing peanuts contaminated peanut butter led to a lot of people sick. In these adverse events led to investigate the cause found, except for some other reasons, the supplier\\ s control is inadequate or not in place one of the reasons. U.S. FDA issued to medical device manufacturers observations and warning letters to 19 from 2006 to 2007 25 and 2008 35.
These events have caused the United States and European regulatory agencies to strengthen the medical device and pharmaceutical industries suppliers control. In December 2008, the global coordination group (GHTF) issued a guidance document, lists the manufacturers of medical equipment suppliers in the control process must include steps.
November 2009 issued a second document (in draft form) describes the inspection of medical device manufacturers suppliers control techniques. In 2009, AdvaMed Conference, from the U.S. FDA AdvaMed, said, \"Compared to 2007, the supplier management and control issues is a growing problem, although there are issues of toothpaste and peanut products and equipment sector is not directly related However, these events are still greatly influenced the thinking and the U.S. FDA\\ s control. control of the supplier and the relationship between risk management will continue to increase the attention. \"
The level and extent of control should be based on the importance of product or service and risks that may affect the final product safety, efficacy, and the importance of quality and risk. The final product or device manufacturer has the responsibility and their suppliers to identify and communicate these requirements. Good supplier management and control can be converted into an effective quality management systems and risk management processes, high quality and consistent products, productivity improvements and waste, adverse events, complaints and recalls reduced.
For medical device manufacturers and healthcare industries components, parts and raw materials suppliers must be prepared to meet its customers from more stringent controls. Suppliers control the level and extent will depend not only on the suppliers of the importance and risks of the product, including the supplier in the supply chain in the position. Compared to level 2 and 3 suppliers, supplier of level 1 management and control more (see Figure 1). Both material suppliers in the value chain in what position, they still must ensure that its products meet all the performance and application-specific regulatory requirements.
The medical industry supply chain, many companies do not fully understand the risks for their products and changes come from. In some cases, they believe that the risk of medical equipment and pharmaceutical market high and low profits. A small number of vendors have developed a class of special programs for the needle in this market with its products and services. LyondellBasell, Clariant and every aspect of their supply chain to work closely not only to reduce their own risk and its direct customers, and ultimately reduce drug and medical device company\\ s risk. LyondellBasell is a PE (polyolefin) resin suppliers, its customers include a variety of industries, including health care industry. The two companies have services for the healthcare industry for decades, and has passed a similar approach to ensure that their business processes and health care products are ready to respond to a tightening of control challenges.
Medical device and pharmaceutical industries continue to use the high performance characteristics of the plastic, and use the number is increasing. These materials must meet specific characteristics, such as can be disinfected, resistant to chemicals and lipids, biological compatibility. Impurities, the extract or leachate at a slight difference on the final formulation may affect the biocompatibility and toxicity of the product. United States Pharmacopeia (USP) and European Pharmacopoeia (Eur.Ph) requirements (supplier) to provide the material composition and formula, production technology and the physical and mechanical properties, chemical properties, biocompatibility and toxicity testing of a large number of test data. These results must be placed in a specific file, or material must meet the standards set forth in the property requirements. Advantage of this system is that product manufacturers can design and products in their use of these materials and is confident that its products meet regulatory and application requirements. However, the shortcomings of this system is that the document or record is submitted when the second application, and the use of materials and formulations are very specific. As time goes on to make any material changes or formula is not an easy task, and from the commercial and regulatory point of view have become a difficult task.
In order to meet the health care industry and its customers\\ changing requirements and needs, Clariant and LyondellBasell have implemented a strategic business processes, which relate to their customers (health care products developer and manufacturer of the product, brokers and processors, the industry associations, etc.) and suppliers (resin, masterbatch, additives, catalysts and other suppliers) common management, control and reduce the supply of its products to the healthcare industry risk.
Clariant is a professional manufacturer of specialty chemical products listed international company headquartered in Switzerland. The company has multiple business units (BU) to the medical device and pharmaceutical industries intermediates, excipients and masterbatch products. In the masterbatch for the plastics processing industry and additives, and mixtures, BU Masterbatch is a famous brand. Plastics processing industry ranging from consumer electronics, toys, food, personal care packages, textiles and automotive parts. The company\\ s focus on the health care industry to implement the strategy include a risk-based program designed to be controllable, stable and compliant products. Business unit focused on the distribution of the three global center of expertise for analysis, so that it can provide a complete medical materials for the production line isolation. These centers have the production of goods based on the current practice of quality management system, and the implementation of ISO 13485 standards for medical equipment. The three technology center has two external authentication is complete, the rest of this home in 2010 after an external certification. Process for medical products and production processes including the production of batches of fully traceable, an \"open to review\" policy (the policy to encourage direct customer and brand owner for review) and strict change control process. Eventually launched two products for medical and pharmaceutical applications of the new internal classification: MedCat 1 and MedCat 2, also released a product for traditional products and services and to distinguish the new brand. Notice of material changes to the company, process control, risk management, quality management system and document the level of control compared to the standard mixture and masterbatch production plants are different from the conventional process.
LyondellBasell, the world\\ s largest suppliers of the PE material. Purell is a development of materials for the medical industry, PP and PE material brands. Purell is the value of the product formulation and stability of supply, purchased separately, backup facility and meet the pharmacopoeia requirements. LyondellBasell Company introduced a series of specialized products for medical applications, and have a special internal quality systems and procedures, which the pharmaceutical and medical device practice the essence of production of goods. Control the risk management process is the integral part of the process.
Clariant and LyondellBasell\\ s work together to train medical and pharmaceutical suppliers. The supplier of the polymer, a mixture of masterbatch and implement change control, they are establishing the importance of change control and the significance of understanding. The use of risk management products used to control the medical industry, is also part of their strategy. The two companies agreed that the risk with the complexity of the supply chain increases, and has developed strategies to mitigate these risks and management of raw materials change, consistency and quality. Clariant has been collaboration with its suppliers to provide quality and purity and stability of masterbatch and additives. These chemicals change the less, the more confident you will not change the different batches of masterbatch products, bio-compatibility and toxicity. Clariant\\ s global markets division of consumer products and medical head Stephen Duckworth said, \"After an independent study to seek medical equipment and pharmaceutical industry demand, we made in 2008, a reserved and sober investment in this area decision on a change of raw materials and suppliers are common industry requires very aware of the market, including the risk of change come from and we now need the environment in which the culture of these three technology centers, technology and standards and training for our team to change the world we know we do not need to spread around the world throughout our 50 masterbatch production point, we realized that the market (health care market) is different now have customers tell us Our program for the achievement of new levels of security to make a contribution, however, we clearly recognize that if the vision of the entire supply chain, including our suppliers, we still have more work to do. \"
Macroscopic properties of polymers and resins, such as viscosity, flow rate, physical and mechanical properties have been well understood by manufacturers and can be controlled and measured. These physical properties are client applications for health care evaluation and selection of materials. Certificate of Analysis (CoA) and quality standards certificates are also based on these macroscopic properties. LyondellBasell\\ s that for specific medical applications and critical properties such as dissolution and extracts, biocompatibility and toxicity is highly dependent on the microscopic properties of the resin, such as impurities, molecular weight distribution and low molecular weight oligomers . \"Since 2002, LyondellBasell has been developing and marketing for the medical industry customers use the products, we enhance our quality standards, and on how to effectively meet the health care industry need to form a better understanding of the information in our medical policy is to be provided — a concentrated and used to control product consistency, quality and production policies.
This policy is a dynamic concept; it is to be modified regularly to meet growing customer demand, industry standards and the requirements of GMP. This policy is reflected in our Purell brand and products, so our customers to meet their regulatory and application requirements, LyondellBasell\\ s closed system of medical applications and closed head Jochen Schneider said. \"This fall, we work together with our customers, through the application of risk assessment to understand how our resin products for health care applications based on these data, we can provide on whether the resin product for these applications to make comprehensive information about The decision risk assessment based on the EMEA and the Medical Device Directive (MDD) of the risk classification. LyondellBasell such partnerships benefit both companies and their customers, regardless of the supply chain to reduce the risk of end-users or end-to reduce the risk. \"
Supplier management and control is becoming a health care industry product manufacturers quality system in a very important aspect. Regulatory inspections will further emphasize the importance of procurement controls to ensure that these manufacturers based on product risk and the importance of its suppliers to the appropriate extent and level of control. Clariant and LyondellBasell has taken a proactive program for the establishment of its customers reduce risk, reduce the changes and maintain its health care industry products, compliance and the importance of consistency. By taking this action, Clariant and LyondellBasell\\ s ready for those who need to understand the health care industry suppliers and deploy risk-based quality system to provide services to customers.
Ministry of Health requirements: medical use of antibiotics must be publicized
Health, Medical Administration Zhao Gang, deputy director of the Ministry of Health yesterday held a regular press conference that the Ministry of Health requires medical institutions to disclose the unit variety of antibiotics, quantity, size and use, and the proportion of antibiotic drugs, the patients understand the treatment.
In accordance with the provisions of the Ministry of Health, three general hospitals in principle, the type of antibiotics more than 50, two general hospitals should not exceed 35 species, in addition to other pediatric medicine, with a variety of antibiotics, the same size no more than two outpatient antibiotic usage control in less than 20% usage of antibiotics in hospitalized patients to control 60% or less.
Although these indicators have been achieved most medical institutions, but Zhao steel frankly, because the hospital compensation mechanism issues, lack of capacity of individual physician expertise, knowledge and mastery of the masses of inadequate treatment and other reasons, some of the irrational use of antibiotics still exists, In a very few medical institutions and medical personnel who, irrational use of antibiotics are quite serious.
According to reports, the Ministry of Health, "clinical use of antibiotics management approach" has been several drafts, listen to the views of the industry within the healthcare industry, has now entered the final amendments to the document process.
Our health care system, “market” it?
At present, many people believe that our health care system has been "market" of the, and the area of ??health problems in the health care system due to the "market." So, our health care system in the end is not "market" out? In this regard, it is debated, but no clear answer. I believe that it is necessary to sort out this issue, because clearly the status of the system to determine, is the basis for further reform of institutional policy.
Smoke and mirrors
Many experts say that at home and abroad, the Chinese medical and health fields currently existing problems are solved because the "market" caused.
Back in 2003, the Chinese University of Hong Kong, one scholar has written that the reason why China s public health situation deteriorated, "but the main reason is probably connected with us in a vague general idea of ??reform there are two kinds of superstitions about – one is the superstition of economic growth; the other is blind faith in market. "According to his words," the 1990s after the establishment of a market economy was established as the objectives of the reform, medical and health gradually to the market ", while the final result," China s the area of ??health is probably the world s most market-oriented one of the areas. "
2005, issued by a related group of special research report, China since the reforms, "the basic medical and health system change to a commercial, market-oriented" and its negative consequences, "mainly for the decline in medical services and health equity investment macro-inefficient ", and" root of the problem in the commercial, market-oriented direction of the development contrary to the basic medical and health law. "
In the same year, a Peking University s China Center for Economic Research Scholars also published an article pointed out that China s rapid economic growth "is not directly brought about the improvement of people s health", and the increase in investment conditions, "the worse the performance of health care." The scholars believe that "The main reason is state failure and market failure the Government in the reform process in the development of health care there is no clear direction and goals, blindly health care market."
These indicate that several aspects of Chinese medical and health experts have reached a high degree of status consensus, which is the reform and opening up, China s status of health care system has been completely "market." In view of these scholars, because the special nature of health care, resulting in market-oriented health reform route is bound to fail.
Many issues involved here, but in order to clarify the crux, we should first understand our health care system in the end is not completely "market."
Odds with the fact that
For many people, our health care has entered the market-oriented way is a self-evident reality. Is not it? Now people are to spend their own money to see a doctor (whether direct dig individual pockets to pay, or by social security or tax pays for); a number of public and private hospitals not only "Mo money come in sick", but also the use of information and technology dominance, induced Patients see a doctor to spend more money – such and such a buy, a sell, not the market? Sale of medical services so common, is not "market" what is it?
National health care spending for high-speed increase, is it not the "market" to blame?
However, the capacity of the author to ask, when a lot of purchasing power concentrated in health services, when the supply of medical and public health aspects of what has made a response? Is not difficult to answer this question, of course, is the result of the first hospitals and health services of people engaged in "hair", and overtly or covertly income rolling. So, when the demand for medical institutions and practitioners focused on the growth momentum in the next highly profitable market, the phenomenon of what is destined to come one after another?
If this is conclusive experts chisel words "market" and highly profitable practice, once the news came Daihatsu, stop the world heroes determined to "Breaking and Entering" – set up more hospitals and clinics, mobilize more people to study medicine, adding more health services – until the line of business practice of "excess profits" is averaging down.
This means that, if there really "market" in this world, practice and made their fortunes is the first reaction is to mobilize more resources into the second reaction is inevitable. It is clear that the former is the growth in demand caused by changes in income distribution, which is the re-allocation of resources with the price mechanism.
However, I survey found that: 1. People health
The increase in health costs and expenses, a few times even 100 times higher than the increase in clinic visits, thus the cost of each treatment increased rapidly – "expensive" is also; 2 each medical institutions as well as each health care , the average gain should be in service revenues have been significantly increased; 3 Overall productivity of our health services have not improved (although in different hospitals, there are significant differences between); 4 is the most important people a lot of money on health services, to stimulate the supply side, there s no corresponding increase in resource mobilization.
Where seen in this and other "market" mean?
Realistic
Since reform and opening up, Chinese people s daily life use, has undergone great changes. In general, everything from the shortage of hard times into the product an adequate supply of services to improve quickly, inexpensive things flooding the market, which tracks the most basic, is that once concentrated demand, the seller made their fortunes, and soon attracted a large number of "backward elements" to invest in factories set up shop, switch to mobilize human, technical management study, and soon form a production capacity of providers to, and then each of its plan, bargain or competition, or innovation of the strange, until the same has the same products and services into the homes of ordinary people.
It is these horizontal experience, the "Chinese health care market" theory has flaws. Again, I want to debate the question is not "market" is good, this should not, but whether the Chinese health care is not already "market." Some experts, government funding accounts for the decline in the proportion of total health expenditure, as health care "market" basis. I believe that it ignores the question: government spending to reduce the proportion of health costs at the same time, there is no access to health services on the door? Another expert said, "various types of capital can enter the field of medical services, basically there is no entry and exit restrictions, the new layout, and services medical institutions targeting depends on market demand conditions." If they are right, why the medical and public health needs to increase so rapidly, the average charges for medical services a few times, a hundred times improved, but did not stimulate the country s medical institutions and a corresponding increase in the number of staff?
Of course, I have no intention to "market" of a unified concept, after all, each on their own which can justify a definition. But I think it is important to pay attention to a real problem, which is China s medical and public health systems, with demand high in the case, why is the ability to mobilize resources to increase the supply so low? I believe that, regardless of what we have argued that this problem is not resolved, to improve health services in China s policy objectives, if not castles in the air, so it is also certain difficulties.
Medical equipment will be a special plan for future growth 20%
.jpg "Gouge stitches")
Authorities from the Ministry of Science and was informed at the exclusive, special focus on Science and Technology \"medical device Industry and Technology Development Plan 2011-2015\" has been completed, to solicit the views of medical device companies are expected to introduce in the near future.
According to Ministry sources, the \"five-second\" period, China will greatly enhance the number of medical devices, intelligent, high precision and networking, to promote the development of domestic medical equipment, the next step is also expected to achieve in the field of medical devices and then manufacturing.
Ministry sources, the \"special plan\" for each high school to support low-end medical equipment. The focus of primary care involves basic equipped with 10 categories, and is expected to promote the appropriate conditions of inexpensive high-quality ultrasound ultrasound equipment; in high-end products focused on solving the problem of high-value consumables, and strive to achieve the pricing; medical services will be supported.
The source said that since 2008, China launched a national medical device industry research, the basic information currently available. The current domestic medical device industry is characterized by: small quantities, but the profit margin is high; products are public goods, property, belonging to the Government pay range; distinctive characteristics of high-tech industry sectors, innovation is very fast, get the policy of great concern.
China Medical Device Industry Association Expert Committee Wang Xiaoqing, said medical device development is now showing a trend of integrated development, corporate sales will not only equipment, but the integrity of services and comprehensive solutions, home medical equipment, surface to primary health care equipment and medical devices based on wireless networks and so may gain a larger market.
It was explained that the hospital is not a major grass-roots community organization of medical diagnosis, but the future operation of the rehabilitation process of the main executive body, therefore, home medical equipment is expected to seize a beachhead in the community hospital.
Medical device industry scattered, chaotic features the same attention. Mindray Bio-Medical Electronics Co., Ltd., Hang Xu, China\\ s total number of medical device companies a total area of ??about 14,000, but sales of more than 1 billion less than 200 enterprises. Industry shows that high-tech, multi-disciplinary, complex production process, as well as mainstream SMEs, big gap between the overall strength of the status quo. However, the global market, 70% of medical equipment sales focus on the first 30 companies in the hands.
Secondary market, the investment value of the medical device industry is also promising. 10 medical device sector contrarian outstanding performance, Improve Medical (300,030 valuation, assessment, market, information, main trading) (300,030 valuation, assessment, market, information, the main trading), nine medical safety (002,432 valuation, evaluation, market, information, main trading) (002,432 valuation, assessment, market, information, the main trading) limit two stock, music universal health care (300,003 valuation, assessment, market, information, main trading) (300,003 valuation, assessment market, information, the main trading), diving medical (002,223 valuation, assessment, market, information, main trading) (002,223 valuation, assessment, market, information, the main trading) and others doing well.
Minsheng Securities Research, said the domestic demand for medical devices is getting better, and downward pressure on prices is small, with the new rural cooperative medical insurance co-ordination to increase the proportion of urban residents, patients will become more accurate diagnosis requires a high, strong demand for various types of diagnostic equipment.
It is understood that the current height of the domestic low-end test equipment has passed, the field of foreign high-end equipment, absolute advantage, high-quality home medical equipment company is expected to become a good investment targets.
Comments: Minsheng Securities Research, said the domestic demand for medical devices is getting better, and downward pressure on prices is small, with the new rural cooperative medical insurance co-ordination to increase the proportion of urban residents, the exact diagnosis of patients require increasingly high demand for various types of diagnostic equipment strong.
Future of the industry a 20% compound growth medical device market leveraging the Blue Book
October 31-November 3, the 66th China International Medical Equipment (Autumn) Fair (CMEF) was successfully held in Fuzhou.
\"2011 annual report of China\\ s medical industry\" blue book came out, the \"Blue Book\" by Reed Sinopharm CMEF together world-renowned consulting firm Frost & Sullivan took six months to complete, is the most recent influential Chinese medical industry, a research report. Because of them predict the future of China\\ s medical device industry will be rapid growth, which led to the recent medical device market.
Forecast 20% compound growth of the industry\\ s future
According to the \"Blue Book\" described in the next five years, China\\ s medical device industry, the three main driving factors: First, the national \"five\" plan to encourage social capital to enter the health care field; Second, the new medical reform plan to phase out hospital drug addition , hospital charges for medical services will become the main source of income, the hospital will increase investment in medical equipment; third, according to national \"five\" plan, the new focus on medical and health resources to the rural and urban communities tilt, which makes low-end medical equipment market needs to expand the domestic enterprises in particular.
Another driving factor is: First, some domestic high-quality medical device companies have listed, on the one hand regulate the operation of enterprises, on the other hand can contribute to new product development through financing and the establishment of overseas markets; Second, the Chinese medical device market share in China 14% of the pharmaceutical market, while the global medical device market share of the total pharmaceutical market size ratio of 42%, which means that the Chinese medical device market is still much room for development; Third, China\\ s urbanization process and the acceleration of the aging population, resident self-care awareness, increase public awareness of medical and health services.
Based on the above factors, the \"Blue Book\", said the next five years, China\\ s county-level hospitals for medical imaging equipment, testing equipment and information technology equipment demand will increase significantly, and forecasts, 2011 to 2015 China\\ s medical device industry compound annual growth rate could reach 20.1%.
Gastrointestinal endoscopy equipment in 2016 the United States will more than double the market value of
The main authority of the medical device according to iData Research\\ s research, the gastrointestinal endoscopy market is expected to be the United States to double-digit growth rate, by 2016 the output value will exceed $ 1.8 billion. Some of the faster growing markets, including anti-reflux market value in 2011 is expected to be three times now. 2016 esophageal stent market is expected to grow double-digit growth, because in some cases, surgeons, such as weight loss treatment, will stand as an additional tool.
Gastrointestinal endoscopy is an ideal detection method can be used for diagnosis and treatment of gastrointestinal diseases. Gastrointestinal Endoscopy Endoscopy is the largest market segment in 2009, accounting for 32% of the market. However, with the capsule camera technology continues to progress, expected 2016 capsule endoscopy device will become the second largest market segment. In addition, the ultrasound endoscope market is expected to grow 16% compound annual growth rate of growing.
Kamran Zamanian \"in 2009 in the digestive tract endoscopy, colonoscopy accounted for nearly 50%, reflecting the early diagnosis of colorectal cancer of the colon checked regularly increasing frequency,\" iData\\ s CEO Dr. Kamran Zamanian said. \"And because reimbursement issues and concerns relative to the effectiveness of colonoscopy there is a problem, simulated colonoscopy will maintain moderate growth.\"
Application of stem cells would be promising in the treatment of diabetes
At the recent national stem cell transplantation in the treatment of type 2 diabetes, the clinical application of the meeting, experts said, the application of stem cells in the treatment of diabetes will be promising.
PLA Military Academy of Medical Sciences, Professor Kuo wide introduction, diabetes due to islet cell dysfunction or insulin resistance caused by insufficient insulin secretion caused by absolute or relative. Thus, to prevent cell function decline, increased cell number, rescue and recovery to maximize islet function, new ideas for the treatment of diabetes. The stem cells their unique biological characteristics, strong self-renewal and differentiation potential, making it the best access to the islet cells "seed" cells for clinical treatment of diabetes, a new approach.
Honorary Director of Diabetes Center of Peking University, Beijing Rui Jing diabetes honorary president Professor Qian Rongli Hospital, said stem cell transplants for diabetes patients, in addition to specialized medical care and provide tracking and detection, but also the associated psychological counseling and individual of fine nutritional guidance to improve stem cell transplantation for treatment of patients with a correct understanding, reduce stress, enhance physical confrontation, and really promote the speedy recovery of patients after surgery.